GlassScriptPhysician profile
Alex Uhr
NPI 1295199396
$12,612.89
in general payments reported to CMS, 2019-2025
36 companies · $2,722 in 2025
The $2,722 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $959 · 2022: $3,204 · 2023: $2,044 · 2024: $3,584 · 2025: $2,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,679 · Travel and Lodging: $1,180 · Consulting Fee: $400 · Education: $90.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,679.19 |
| Travel and Lodging | $1,180.27 |
| Consulting Fee | $400.00 |
| Education | $90.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,620.26 | 2021-2025 | General - Erectile Dysfunction, Ams 700 |
| Medtronic, INC. | $2,200.42 | 2022-2025 | Interstim, Concertotm |
| Coloplast Corp | $1,041.36 | 2021-2024 | |
| Dentsply Ih Ab | $940.08 | 2023-2025 | Lofric, Lofric |
| Astellas Pharma US INC | $731.15 | 2020-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $426.17 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $415.73 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $408.89 | 2022-2025 | Urolift, Barrigel |
| Photocure INC | $237.83 | 2021-2022 | |
| Janssen Biotech, INC. | $235.82 | 2021-2025 | Erleada |
| Janssen Scientific Affairs, LLC | $167.93 | 2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $156.58 | 2023-2024 | Prolaris |
| 180 Medical, INC. | $122.66 | 2023-2025 | Gentlecath |
| Ferring Pharmaceuticals INC. | $112.19 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $111.97 | 2023-2025 | Jelmyto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $91.38 | 2023 | Da Vinci Surgical System |
| Progenics Pharmaceuticals, INC. | $83.07 | 2024-2025 | |
| Pfizer INC. | $76.65 | 2025 | |
| Dentsply Ih INC. | $66.31 | 2022 | |
| Olympus America INC. | $54.59 | 2025 | Itind System |
| Ambu INC. | $27.79 | 2021 | |
| Convatec INC. | $23.56 | 2022 | |
| Abbvie INC. | $23.31 | 2024 | |
| Merck Sharp & Dohme LLC | $22.98 | 2022 | |
| Accord Healthcare, INC. | $22.89 | 2022 | |
| Telix Pharmaceuticals | $20.48 | 2024 | Illuccix |
| Myovant Sciences INC. | $20.23 | 2022 | |
| Calyxo, INC. | $19.63 | 2025 | Cvac Aspiration System |
| Genzyme Corporation | $19.34 | 2022 | |
| Allergan, INC. | $18.60 | 2021 | |
| Sun Pharmaceutical Industries INC. | $18.05 | 2023 | Yonsa |
| Avation Medical, INC. | $15.65 | 2025 | Vivally System |
| Baxter Healthcare | $15.30 | 2020 | |
| Mission Pharmacal Company | $15.08 | 2024 | Uribel Tabs |
| Immunitybio, INC. | $14.85 | 2024 | |
| Urovant Sciences INC | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Uhr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.